Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy

PURPOSE: To report our initial experience with 1.5 T magnetic resonance imaging (MRI) linear accelerator (LINAC) in prostate cancer radiotherapy in terms of its use in a radiation oncology clinic. METHODS: The medical records of 14 prostate cancer patients treated with MRI-guided radiotherapy were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Turkkan, Gorkem, Bilici, Nazli, Sertel, Huseyin, Keskus, Yavuz, Alkaya, Sercan, Tavli, Busra, Ozkirim, Muge, Fayda, Merdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424496/
https://www.ncbi.nlm.nih.gov/pubmed/36052268
http://dx.doi.org/10.3389/fonc.2022.909402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424496/
https://www.ncbi.nlm.nih.gov/pubmed/36052268
http://dx.doi.org/10.3389/fonc.2022.909402

Ejemplares similares